ESC Congress 2011

27 - 31 August 2011, Paris - France

Session Details

Poster session 5: New insights into the pathophysiology of aortic valve disease
Tue 30 Aug 08:30 - 12:30 Valvular heart disease, other Poster Session Posters - Poster Zone C

Abstract Slides/e-posters Video Report

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
08:30P4345Statin use reduces neoangiogenesis and intraleaflet haemorrhage in the aortic valve of degenerative aortic stenosisHirokuni AKAHORI (Nishinomiya, JP)
08:30P4346Increased thrombin generation and platelet activation as a compensatory mechanism in patients with aortic stenosis and acquired deficiency in high-molecular-weight vWF multimersAnetta UNDAS (Krakow, PL)
08:30P4347Growth differentiation factor-15 AND ST2 levels in patients undergoing elective aortic valve surgeryJeffrey KHOO (Grantham, GB)
08:30P4348The severity of myocardial fibrosis in aortic stenosis is related to upregulation of procollagen type I C-terminal proteinaseFelix VALENCIA SERRANO (Malaga, ES)
08:30P4349Serum osteoprotegerin and RANKL levels in patients with bicuspid and tricuspid aortic stenosisOlga MOISEEVA (St-Petersburg, RU)
08:30P4350Active aortic valve calcification and inflammation in patients with aortic stenosis: a PET-CT studyMarc DWECK (Edinburgh, GB)
08:30P4351Wall shear stress in the ascending aorta in patients with bicuspid aortic valves differs significantly from tricuspid aortic valvesSohrab FRATZ (Munich, DE)
08:30P4352The association between bicuspid aortic valve function on circulating endothelial progenitor cells Mordehay VATURI (Petah-Tikva, IL)
08:30P4353Echocardiography and collagen markers in "low flow and high gradient" aortic stenosisKatarzyna PIESTRZENIEWICZ (Lodz, PL)
08:30P4354Angiogenesis in degenerative aortic valve diseaseAdelheid PANZENBOECK (Wien, AT)
08:30P4355Association of sclerostin serum levels with the severity of aortic valve calcificationRalf KOOS (Aachen, DE)
08:30P4356Neoangiogenesis, intraleaflet haemorrhage and macrophage infiltration are more remarkable in bicuspid aortic valve stenosis than in tricuspid aortic valve stenosisHirokuni AKAHORI (Nishinomiya, JP)
08:30P4357The imbalance between proliferation and apoptosis contributes to degeneration of aortic valves and bioprostheses - implications for FKBP12 therapeutic modulationsIzabela TULETA (Bonn, DE)
08:30P4358Insights into the initiation of aortic stenosis: roles of ACE-inhibitors and vitamin DAaron SVERDLOV (Newtonville, US)
08:30P4359Tissue factor expressed by aortic valve interstitial cells is able to generate thrombin in vitroJoke BREYNE (Menen, BE)
08:30P4360Relationship between insulin resistance and progression of left ventricular hypertrophy in patients with aortic stenosis: a substudy of the ASTRONOMER trialRomain CAPOULADE (Quebec, CA)
08:30P4361Phenotypes of bicuspid aortic valve disease and correlations with ascending aortic dilatation by cardiovascular magnetic resonanceAntonio SALVADOR SANZ (Valencia, ES)
08:30P4362MicroRNA expression profile of human aortic valve stenosisPauli Juhani OHUKAINEN (Oulu, FI)
08:30P4363Differences in the secretome of ascending aortic aneurysms from patients with bicuspid or tricuspid valves.Silvia ROCCHICCIOLI (Pisa, IT)
08:30P4364CTGF regulates VSMC phenotypic differentiation and ECM organization, and contributes to the development of thoracic aortic aneurysm in bicuspid and trileaflets aortic valve patientsGiovanni FERRARI (Glenolden, US)
08:30P4365Systematic familial screening identified a high frequency of heritability in calcific aortic valve disease.To Be Announced
08:30P4366Expression of TFPI-2 in diseased aortic valvesJoke BREYNE (Menen, BE)
08:30P4367Aortic stenosis is as much a disease of the myocardium as of the valve - the role of diffuse myocardial fibrosis as measured by EQ-CMRDaniel M SADO (London, GB)
08:30P4368Platelet derived chemokines, PF-4 and RANTES, are significantly increased in hemodynamically significant degenerative aortic stenosisZuzana MOTOVSKA (Prague, CZ)